Where does Highlife SAS rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Highlife SAS ranks #9,277 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Highlife SAS hold?

Highlife SAS holds 34 US utility patents granted between 2015 and 2024, spanning 4 technology areas.

What is Highlife SAS's Innovation Score?

Highlife SAS has an Innovation Score of 35.9 out of 100 (top 48% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Highlife SAS's patent grant rate increasing or decreasing?

Highlife SAS's recent grant velocity is -30% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Highlife SAS's patents?

Highlife SAS's patents average 17.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Highlife SAS patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Highlife SAS

Q: What technology areas does Highlife SAS focus on?

Highlife SAS's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 32 patents, ranking #197 of 3,082 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 34 granted patents across 4 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Highlife ranks #9,277 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 4 technology areas.

#9,277
of 49,997 US assignees by volume: Top 48%
by Innovation Score (35.9/100): 17.6
avg claims per patent: -30%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9277 · Foreign Corporation #9,277 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 34 grants
UPPER-Q #9,277/49,997
PHOTO-FINISH Global Filtration…
CPC-NARROW A61F · 4 areas
INNOV-THIN 35.9/100
CLAIMS-RICH 17.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -30% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Global Filtration Systems (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Highlife’s 35.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.3 pts (34%) Velocity 6.0 pts (17%) Breadth 7.1 pts (20%) Claim depth 10.5 pts (29%)

Qualcomm Incorporated · highest

85
Hangzhou Chic… · near

36
Highlife SAS · this assignee

36
Reestar International · near

36
Stormtrap · near

36
USAI · near

36
3D Lighting… · lowest

7

What this shows Highlife's Innovation Score is 35.9/100 (top 48% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Highlife?

Each dot is one of Highlife’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Highlife’s own 17.6 claims/patent is ABOVE the 11.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Highlife vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Highlife's grants concentrate

Highlife SAS is a focused PatentsView assignee: 4 CPC subclasses with 94.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2018 (6 grants) versus a trough of 1 in 2015. By volume, Highlife sits between Global Filtration Systems and Heron Therapeutics, Inc..

Highlife's three-year grant acceleration

Highlife SAS shows 9 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Global Filtration…

34
Global Oled Techn…

34
Guala Pack S P A

34
Harris Global Com…

34
Horiba Instrument…

34
HS Marston Aerosp…

34
Henke-sass Wolf

34
Heron Therapeutics

34
Highlife SAS ◀

34

What this shows Highlife holds 34 patents at rank #9,275, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Highlife

By rank, the assignees closest to #9,275 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Highlife's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Highlife, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Highlife ranks #197 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

USAI 36 Hangzhou Chic Intelligent Technology Co., Ltd. 36 Reestar International Limited 36 Stormtrap, LLC 36

Highlife's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Highlife SAS patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	2.9%
2016	3	8.8%
2017	5	14.7%
2018	6	17.6%
2019	5	14.7%
2020	2	5.9%
2021	3	8.8%
2022	6	17.6%
2023	1	2.9%
2024	2	5.9%

Which technologies does Highlife SAS patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 32

A61B - DIAGNOSIS; SURGERY; Identification 11

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Highlife SAS's patent record in context - here's where to go next.

Highlife SAS's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 94.1% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #9,277 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Highlife SAS against Global Filtration Systems, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.